SIRT1 and Parkinson disease: The study aimed to screen various phytoconstituents (compounds 1−13) dereplicated from T. aphylla for their ability to bind to the Sirt-1 catalytic domain, with the goal of identifying compounds that can modulate Sirt-1 activity and offer protective effects in the setting of PD (S19 Table).